These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30091962)

  • 1. Safety of Etanercept in the treatment of rheumatic disease patients with Hepatitis C virus infection.
    Teixeira L; Fonseca C; Sousa S; Vinagre F; Cordeiro A; Gonçalves P; Santos MJ; Canas da Silva J
    Acta Reumatol Port; 2018; 43(2):159-160. PubMed ID: 30091962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs.
    Lee YH; Bae SC; Song GG
    Int J Rheum Dis; 2013 Oct; 16(5):527-31. PubMed ID: 24164839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective Study of Patients on Etanercept Therapy for Rheumatic Diseases in Patients With Chronic Hepatitis C Virus.
    Gandhi NP; Manadan AM; Block JA
    J Clin Rheumatol; 2017 Aug; 23(5):252-257. PubMed ID: 28700530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.
    Lin KM; Cheng TT; Lin JC; Chen CJ
    Clin Rheumatol; 2015 Jun; 34(6):1039-46. PubMed ID: 25939523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy.
    Lee YH; Bae SC; Song GG
    Clin Exp Rheumatol; 2013; 31(1):118-21. PubMed ID: 23111095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of HCV eradication during etanercept treatment for severe psoriasis.
    Pescitelli L; Lazzeri L; Tripo L; Ricceri F; Di Cesare A; Prignano F
    Dermatol Ther; 2018 Jul; 31(4):e12614. PubMed ID: 29708289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review.
    Brunasso AM; Puntoni M; Gulia A; Massone C
    Rheumatology (Oxford); 2011 Sep; 50(9):1700-11. PubMed ID: 21690185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatic manifestations of hepatitis.
    Vassilopoulos D; Manolakopoulos S
    Curr Opin Rheumatol; 2010 Jan; 22(1):91-6. PubMed ID: 19864952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term course of chronic hepatitis B and C under treatment with etanercept associated with different disease modifying antirheumatic drugs without antiviral prophylaxis.
    Cansu DU; Kalifoglu T; Korkmaz C
    J Rheumatol; 2008 Mar; 35(3):421-4. PubMed ID: 18203328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C-associated rheumatic disorders.
    Buskila D
    Rheum Dis Clin North Am; 2009 Feb; 35(1):111-23. PubMed ID: 19481000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are Anti-TNF-α Agents Safe for Treating Psoriasis in Hepatitis C Virus Patients with Advanced Liver Disease? Case Reports and Review of the Literature.
    Di Nuzzo S; Boccaletti V; Fantini C; Cortelazzi C; Missale G; Fabrizi G; Lotti T; Hercogová J; Pagliarello C
    Dermatology; 2016; 232(1):102-6. PubMed ID: 26444967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.
    Vassilopoulos D; Apostolopoulou A; Hadziyannis E; Papatheodoridis GV; Manolakopoulos S; Koskinas J; Manesis EK; Archimandritis AI
    Ann Rheum Dis; 2010 Jul; 69(7):1352-5. PubMed ID: 20472596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV Treatments and Their Integration Into Rheumatology.
    Vassilopoulos D; Calabrese LH
    Curr Rheumatol Rep; 2015 Aug; 17(8):51. PubMed ID: 26113012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
    Bonifati C; Lora V; Graceffa D; Nosotti L
    World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection.
    Caso F; Cantarini L; Morisco F; Del Puente A; Ramonda R; Fiocco U; Lubrano E; Peluso R; Caso P; Galeazzi M; Punzi L; Scarpa R; Costa L
    Expert Opin Biol Ther; 2015 May; 15(5):641-50. PubMed ID: 25652590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations.
    Mori S; Fujiyama S
    World J Gastroenterol; 2015 Sep; 21(36):10274-89. PubMed ID: 26420955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection.
    Ferri C; Ferraccioli G; Ferrari D; Galeazzi M; Lapadula G; Montecucco C; Triolo G; Valentini G; Valesini G;
    J Rheumatol; 2008 Oct; 35(10):1944-9. PubMed ID: 18688917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial.
    Iannone F; La Montagna G; Bagnato G; Gremese E; Giardina A; Lapadula G
    J Rheumatol; 2014 Feb; 41(2):286-92. PubMed ID: 24429167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register.
    Lie E; Lindström U; Zverkova-Sandström T; Olsen IC; Forsblad-d'Elia H; Askling J; Kapetanovic MC; Kristensen LE; Jacobsson LTH
    Ann Rheum Dis; 2017 Sep; 76(9):1515-1521. PubMed ID: 28254789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.